Requirement of leucine-rich repeats of glycoprotein (GP) Ibα for shear- dependent and static binding of von willebrand factor to the platelet membrane GP Ib-IX-V complex

Blood

Volumn 95, Issue 3, 2000, Pages 903-910

  Shen, Yang ^c   Romo, Gabriel M ^c   Dong, Jing Fei ^c   Schade, Alicia ^c   McIntire, Larry V ^c   Kenny, Dermot ^a   Whisstock, James C ^c   Berndt, Michael C ^c   López, José A ^c   Andrews, Robert K ^b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTROCETIN; GLYCOPROTEIN IB; LEUCINE; RISTOCETIN; THROMBIN RECEPTOR; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CHIMERA; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ADHESION;

EID: 12944317287     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.3.903.003k37_903_910     Document Type: Article

References (45)

1. Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis. 1994;5:97.
2. Weiss HJ. Flow-related platelet deposition on subendothelium. Thromb Haemost. 1995;74:117.
3. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood. 1996;88:1525.
4. Andrews RK, Lopez JA, Berndt MC. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol. 1997;29:91.
5. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost. 1997;78:611.
6. Savage B, Salvidar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996; 84:289.
7. Savage B, Almus-Jacobs F, Ruggeri ZM. Synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94:657.
8. Goto S, Ikeda Y, Salvidar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest. 1998;101:479.
9. Dong J-F, Li CQ, Lopez JA. Tyrosine sulfation of the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry. 1994;33:13,946.
10. Dong J-F, Huyn W, Lopez JA. Aggregation of mammalian cells expressing the platelet glycoprotein GP Ib-IX complex and the requirement for tyrosine sulfation of GP Ibα. Blood. 1995;86:4175.
11. Marchese P, Murata M, Mazzucato M, et al. Identification of three tyrosine residues of glycoprotein Ibα with distinct roles in von Willebrand factor and α-thrombin binding. J Biol Chem. 1995;270:9571.
12. Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin. Biochemistry. 1996; 35:4929.
13. Kobe B, Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature. 1993;366:751.
14. Kobe B, Deisenhofer J. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature. 1995;374:183.
15. Price SR, Evans PR, Nagai K. Crystal structure of the spliceosomal U2B″-U2A′ protein complex bound to a fragment of U2 small nuclear RNA. Nature. 1998;394:645.
16. Miller JL, Lyle VA, Cunningham D. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ibα leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood. 1992;79:439.
17. Ware J, Russell SR, Marchese P, et al. Point mutation in a leucine-rich repeat of platelet glycoprotein Ibα resulting in the Bernard-Soulier syndrome. J Clin Invest. 1993;92:1213.
18. Lopez JA, Andrews RK, Afsahar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood. 1998;91:4397.
19. Miller JL. Platelet-type von Willebrand disease. Thromb Haemost. 1996;75:865.
20. Murata M, Ware J, Ruggeri ZM. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ibα demonstrating negatively charged residues involved in von Willebrand factor binding. J Biol Chem. 1990;266:15,474.
21. Lopez JA, Chung DW, Fujikawa K, Hagen FS, Papayannopoulou T, Roth GJ. Cloning of the α chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich α2-glycoprotein. Proc Natl Acad Sci U S A. 1987; 84:5615.
22. Kenny D, Morateck PA, Fahs SA, Warltier DC, Montgomery RR. Cloning and expression of canine glycoprotein Ibα. Thromb Haemost. 1999;82: 1327.
23. Read MS, Shermer RW, Brinkhous KM. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci USA. 1978;83:4514.
24. Booth WJ, Furby FH, Berndt MC, Castaldi PA. Factor VIII/von Willebrand factor has potent lectin activity. Biochem Biophys Res Commun. 1984; 118:495.
25. Berndt MC, Du X, Booth WJ. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 1988;27: 633.
26. Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Berndt MC. Purification of botrocetin from Bothrops jararaca venom: analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 1989; 28:8317.
27. Lopez JA, Leung B, Reynolds CC, Li CQ, Fox JEB. Efficient plasma membrane expression of a functional human glycoprotein Ib-IX complex requires the presence of its three subunits. J Biol Chem. 1992;267:12,851.
28. Ruan C, Du X, Xi X, Castaldi PA, Berndt MC. A murine antiglycoprotein Ib complex monoclonal antibody, SZ2, inhibits platelet aggregation induced by both ristocetin and collagen. Blood. 1987;69:570.
29. Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem. 1986;261:12,579.
30. Vicente V, Houghten RA, Ruggeri ZM. Identification o1 a site in the a chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. J Biol Chem. 1990;265:274.
31. Mazzucato M, De Marco LD, Masotti A, Pradella P, Bahou WF, Ruggeri ZM. Characterization of the initial α-thrombin interaction with glycoprotein Ibα in relation to platelet activation. J Biol Chem. 1998;273:1880.
32. Montgomery RR, Kunicki TJ, Taves C, Pidard D, Corcoran M. Diagnosis of Bernard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood. J Clin Invest. 1983;71:385.
33. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood. 1983;61:99.
34. Yamamoto N, Kitagawa H, Tanoue K, Yamazaki H. Monoclonal antibody to glycoprotein Ib inhibits both thrombin- and ristocetin-induced platelet aggregations. Thromb Res. 1985;39:751.
35. Mazurov AV, Vinogradov DV, Vlasik TN, Repin VS, Booth WJ, Berndt MC. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Thromb Res. 1991;62:673.
36. Fujimura Y, Titani K, Usami Y, et al. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry. 1991;30:1957.
37. Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK. Identification of Asp-514 to Glu-542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanisms of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry. 1992;31:11,144.
38. Li CQ, Dong J-F, Lanza F, Sanan DA, Sae-Tung G, Lopez JA. Expression of glycoprotein GP V in heterologous cells and evidence for its association with GP Ibα in forming a GP Ib-IX-V complex on the cell surface. J Biol Chem. 1995;270:16,302.
39. Fredrickson BJ, Dong J-F, McIntire LV, Lopez JA. Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex Blood. 1998;92:3684.
40. Read MS, Smith SV, Lamb MA, Brinkhous KM. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood. 1989;74:1031.
41. Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thromb Haemost. 1990;64:326.
42. Azuma H, Sugimoto M, Ruggeri ZM, Ware J. A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib. Thromb Haemost 1993;69:192.
43. Cranmer SL, Ulsemer P, Cooke BM, et al. Glycoprotein GP Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow: importance of the GPIb/actin-binding protein ABP-280 interaction in maintaining adhesion under high shear. J Biol Chem. 1999;274:6097.
44. Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. J Biol Chem. 1991;266: 18,172.
45. Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib. Thromb Haemost. 1990;63:122.